Concepedia

Author

K Szántó

University of SzegedORCID

Also Known As

K J Szántó, K SZANTO, K Szanto, K Szàntó, K Szánto, K Szántó, K Szăntŏ, K. SZANTO, K. Szántó, K. Szántό

103

Publications

373

Citations

11

H-Index

13

Concepts

All Affiliations

University of SzegedSemmelweis UniversityUniversity of PecsHUN-REN Szegedi Biológiai KutatóközpontInstitute of Biochemistry
KS

About

K Szántó is an author at University of Szeged specializing in gastroenterology, medicine, and surgery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

60

2

Gastroenterology

3

3

60

3

Pathology

1

1

12

4

Pharmacology

1

1

14

5

Clinical Epidemiology

1

1

12

K Szántó

×

10

Publications

168

Citations

10

H-Index

YearCitations

Outcomes of Patients With Inflammatory Bowel Diseases Switched From Maintenance Therapy With a Biosimilar to Remicade

Ákos Iliás, K Szántó, Lóránt Gönczi,

Clinical Gastroenterology and Hepatology

2019

34

Functional Anatomical Changes in Ulcerative Colitis Patients Determine Their Gut Microbiota Composition and Consequently the Possible Treatment Outcome

Anita Bálint, Klaudia Farkas, Orsolya Méhi,

Pharmaceuticals

2020

25

Infliximab biosimilar CT-P13 therapy is effective and safe in maintaining remission in Crohn’s disease and ulcerative colitis – experiences from a single center

Klaudia Farkas, Mariann Rutka, Tamás Ferenci,

Expert Opinion on Biological Therapy

2017

24

Clinical efficacy, drug sustainability and serum drug levels in Crohn's disease patients treated with ustekinumab – A prospective, multicenter cohort from Hungary

Lóránt Gönczi, K Szántó, Klaudia Farkas,

Digestive and Liver Disease

2021

14

Effects of bowel cleansing on the composition of the gut microbiota in inflammatory bowel disease patients and healthy controls

Péter Bacsúr, M Rutka, András Asbóth,

Therapeutic Advances in Gastroenterology

2023

14

Biological therapy and surgery rates in inflammatory bowel diseases – Data analysis of almost 1000 patients from a Hungarian tertiary IBD center

K Szántó, Tibor Nyári, Anita Bálint,

PLoS ONE

2018

12

Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis – results from multicenter observational cohort

Anita Bálint, Mariann Rutka, Martin Kolář,

Expert Opinion on Biological Therapy

2018

12

Ustekinumab is associated with superior treatment persistence but not with higher remission rates <i>versus</i> vedolizumab in patients with refractory Crohn’s disease: results from a multicentre cohort study

Péter Bacsúr, Mária Matúz, Tamás Resál,

Therapeutic Advances in Gastroenterology

2022

12

Endoscopic treatment of gastric antral vascular ectasia in real‐life settings: Argon plasma coagulation or endoscopic band ligation?

Anna Fábián, Renáta Bor, Ella Szabó,

Journal of Digestive Diseases

2020

11

Epidemiology, mortality and prevalence of colorectal cancer in ulcerative colitis patients between 2010-2016 in Hungary – a population-based study

Péter Kunovszki, Ágnes Milassin, Judit Gimesi-Országh,

PLoS ONE

2020

10

Page 1